Semaglutides effects on weight loss, inflammation, and pain The semaglutide group also experienced an average 10.5% decrease in body weight compared to only an average 2% decrease in the placebo group
The best option depends on your health history, weight loss goals, and provider recommendations
Causality between tirzepatide and true gastroparesis has not been established, though rare severe GI motility events have been reported with GLP-1 receptor agonists in postmarketing surveillance
Improved Blood Pressure New England Journal of Medicine study on tirzepatide for obesity treatment, describes the Mounjaro results as spectacular, and for those in the highest weight categories, comparable with bariatric surgery results
By targeting three distinct hormonal pathways, it offers a multi-dimensional approach to metabolic health and weight regulation